Showing results (211-220 of 858) with videos related to
Sort By:
Pageof 86
Journal of Neuroscience Research|December 31, 2008
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa responseMartin Köllensperger, Nadia Stefanova, Anton Pallua, et al.Acta Neuropathologica|May 24, 2003
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)Nadia Stefanova, Zoe Puschban, Pierre-Olivier Fernagut, et al.Neurogenetics|March 14, 2012
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patientsMascha C Schmied, Sonja Zehetmayer, Markus Reindl, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2022
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndromeEva-Maria Wendel, Annikki Bertolini, Lampros Kousoulos, et al.Stroke|April 26, 2008
Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck populationAli R Afzal, Stefan Kiechl, Yousef P Daryani, et al.Plos One|October 11, 2007
Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based studyQingzhong Xiao, Stefan Kiechl, Seema Patel, et al.Frontiers in Psychology|April 17, 2023
The psychological impact of genocide on the YazidisJan Ilhan Kizilhan, Thomas Berger, Laura Sennhauser, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2021
Kurt Jellinger 90: his contribution to neuroimmunologyAssunta Dal-Bianco, Romana Höftberger, Hans Lassmann, et al.European Journal of Neurology|October 22, 2020
Immunology of COVID-19 and disease-modifying therapies: The good, the bad and the unknownTobias Zrzavy, Isabella Wimmer, Paulus S Rommer, et al.Journal of Medical Economics|December 8, 2018
Cost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in AustriaEvelyn Walter, Thomas Berger, Barbara Bajer-Kornek, et al.Pageof 86